Clinical Trial Update: Immuno,Safety of GSK Vaccine 134612 Given at Age of 12-15 Months 15-18 Months Post-priming With GSK Vaccine 792014 [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating safety of GSK vaccine given at 12-15 months and 15-18 months post-priming with GSK vaccine 792014 for meningococcal infection; s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meningococcal Infections

Drugs mentioned

• GSK Vaccine 134612
• GSK Vaccine 792014

Snippet

Sponsor: GlaxoSmithKline | Conditions: Infections, Meningococcal | Phase 3 | Status: COMPLETED | Results posted: 2012-07-20